METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE) DIN 02245408
Health Canada record
| Active ingredient(s) | METHYLPREDNISOLONE ACETATE 80 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intrasynovial; Soft Tissue Injection; Intra-Articular; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H02AB04 METHYLPREDNISOLONE |
| Original market date | 10-Apr-2003 |
| Current status date | 16-Apr-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHYLPREDNISOLONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00828920 | DEPO-MEDROL | ZOETIS CANADA INC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Marketed |
| 00030767 | DEPO-MEDROL | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 80 MG | Marketed |
| 00030759 | DEPO-MEDROL | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Marketed |
| 01934341 | DEPO-MEDROL | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 80 MG | Marketed |
| 01934333 | DEPO-MEDROL | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Marketed |
| 01934325 | DEPO-MEDROL | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 20 MG | Marketed |
| 00260428 | DEPO-MEDROL WITH LIDOCAINE | PFIZER CANADA ULC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG; LIDOCAINE HYDROCHLORIDE 10 MG | Marketed |
| 02518139 | TARO-METHYLPREDNISOLONE INJECTION | TARO PHARMACEUTICALS INC | Suspension | METHYLPREDNISOLONE ACETATE 80 MG | Approved |
| 02518120 | TARO-METHYLPREDNISOLONE INJECTION | TARO PHARMACEUTICALS INC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Approved |
| 00517097 | CENTRA MEDRIN | CENTRAL SALES LIMITED | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 00828912 | DEPO-MEDROL STERILE AQUEOUS SUSPENSION 20MG/ML | PHARMACIA ANIMAL HEALTH | Suspension | METHYLPREDNISOLONE ACETATE 20 MG | Cancelled Post Market |
| 00712671 | DEPOCOID 40 | AYERST VETERINARY LABORATORIES | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 00252395 | MEDROL ACNE LOTION | PFIZER CANADA ULC | Lotion | METHYLPREDNISOLONE ACETATE 2.5 MG; ALUMINUM CHLOROHYDRATE 100 MG; SULFUR 50 MG | Cancelled Post Market |
| 00031062 | MEDROL TOPICAL 0.25% | PFIZER CANADA ULC | Cream | METHYLPREDNISOLONE ACETATE 2.5 MG | Cancelled Post Market |
| 02245400 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 02245406 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | Suspension | METHYLPREDNISOLONE ACETATE 80 MG | Cancelled Post Market |
| 02245407 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(40MG/ML WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 00386847 | METHYLPREDNISOLONE ACETATE SUS 40MG/ML | PROFESSIONAL VETERINARY LABORATORIES | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Dormant |
| 00460192 | METHYSONE INJ 40MG/ML | VETCOM 1979 INC. | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 00194867 | NEO-MEDROL | PFIZER CANADA ULC | Cream | METHYLPREDNISOLONE ACETATE 2.5 MG; NEOMYCIN SULFATE 5 MG | Cancelled Post Market |
| 00195057 | NEO-MEDROL ACNE LOTION | PFIZER CANADA ULC | Lotion | METHYLPREDNISOLONE ACETATE 2.5 MG; NEOMYCIN SULFATE 2.5 MG; ALUMINUM CHLOROHYDRATE 100 MG; SULFUR 50 MG | Cancelled Post Market |
| 00552968 | UNI-MED INJ 40MG/ML | UNIVET PHARMACEUTICALS LTD. | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
| 02011689 | VETACORTYL | VETOQUINOL N A INC | Suspension | METHYLPREDNISOLONE ACETATE 40 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7570 | 2005-10-28 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER NAME CHANGE |
| 693 | 2002-03-07 | Abbreviated New Drug Submission (ANDS) |
International API supply for METHYLPREDNISOLONE ACETATE
0 valid EDQM Certificates of Suitability from 0 holders. 7 active FDA Drug Master Files.
Request a quote for METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE)